Know Cancer

or
forgot password

Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area


Phase 1
18 Years
N/A
Open (Enrolling)
Both
Head and Neck Tumors

Thank you

Trial Information

Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area


Inclusion Criteria:



- Recurrent or new head or neck tumor

- 18 years or older

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Maximum tolerated dose.

Outcome Time Frame:

3 months after end of treatment

Safety Issue:

Yes

Principal Investigator

Wilfried De Neve, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital, Ghent

Authority:

Belgium: Institutional Review Board

Study ID:

2007/010

NCT ID:

NCT00528294

Start Date:

February 2007

Completion Date:

September 2013

Related Keywords:

  • Head and Neck Tumors
  • Recurrent head and neck tumors
  • Head and Neck Neoplasms

Name

Location